Kraig Biocraft Laboratories, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $1.8M | $673.3K | $2.6M | $3.9M | — | — | — | $13.7K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | $29.1K | $6.9K | $6.9K | $6.6K | — | — | — | — |
| Total Current Assets | $1.9M | $740.3K | $2.6M | $4.0M | $2.4M | $819.5K | $156.8K | $20.6K |
| Property, Plant & Equipment | $25.0K | $44.7K | $66.6K | $87.9K | $110.9K | $89.2K | $117.3K | $47.3K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $2.6M | $1.5M | $3.2M | $4.6M | $3.0M | $1.3M | $750.9K | $71.4K |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | $540.3K | $587.8K | $600.0K | $560.9K | $793.5K |
| Total Current Liabilities | $10.4M | $9.6M | $8.9M | $8.1M | $8.2M | $7.5M | $5.6M | $4.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $10.6M | $9.7M | $8.9M | $8.1M | $8.3M | $7.9M | $6.1M | $4.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-56.7M | $-53.1M | $-49.7M | $-46.7M | $-42.8M | $-34.8M | $-29.8M | $-26.9M |
| Total Stockholders' Equity | $-8.0M | $-8.1M | $-5.7M | $-3.5M | $-5.3M | $-6.6M | $-5.4M | $-4.5M |